Compare Hecla Mining Company Common Stock (HL) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hecla Mining Company Common Stock vs ImmunityBio Inc. Common Stock — how do they compare? Hecla Mining Company Common Stock trades at $17.31 (market cap $11.24B), while ImmunityBio Inc. Common Stock trades at $10.6 (market cap $10.51B). The key difference: Hecla Mining Company Common Stock and ImmunityBio Inc. Common Stock are close in size by market cap, and Hecla Mining Company Common Stock pays a 0.09% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hecla Mining Company Common Stock for 0 Days and ImmunityBio Inc. Common Stock for 0 Days on average.
| HL | IBRX | |
|---|---|---|
Market Cap | $11.24B | $10.51B |
Volume | 37,227,749 | 10,445,785 |
Sector | Basic Materials | Health |
52-Week High | $31.81 | $11.55 |
52-Week Low | $11.97 | $1.98 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $10.77B | $10.97B |
Dividend Yield | 0.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hecla Mining Company Common Stock
Hecla Mining is a precious metals producer focused on silver and gold. It operates mines in the United States and Canada.
Read more on HL →About ImmunityBio Inc. Common Stock
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →
